Autism and intellectual disability associated with mitochondrial disease and hyperlactacidemia

International Journal of Molecular Sciences

Volumn 16, Issue 2, 2015, Pages 3870-3884

  Guevara Campos, José ^a   González Guevara, Lucía ^b   Cauli, Omar ^c  

^a UNIVERSIDAD DE ORIENTE   (Venezuela)

^b Felipe Guevara Rojas Hospital Epilepsy and Encephalography Unit   (Venezuela)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Autism; Intellectual disability; Muscular tone; Possible mitochondrial disease; Vitamins

Indexed keywords

CARNITINE; CITRATE SYNTHASE; CYANOCOBALAMIN; CYTOCHROME C OXIDASE; FOLIC ACID; LACTIC ACID; METHYL CPG BINDING PROTEIN 2; NICOTINAMIDE; PYRIDOXINE; PYRUVIC ACID; RIBOFLAVIN; RISPERIDONE; SUCCINATE DEHYDROGENASE; THIAMINE; UBIDECARENONE; UBIQUINOL CYTOCHROME C REDUCTASE; VITAMIN B COMPLEX; UBIQUINONE; VITAMIN;

ARTICLE; AUTISM; BLOOD GAS ANALYSIS; BRAIN ATROPHY; BRAIN VENTRICLE DILATATION; CASE REPORT; CHILD; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA EXTRACTION; ELECTROENCEPHALOGRAPHY; ENZYME ACTIVITY; FEMALE; FRAGILE X SYNDROME; GENE MUTATION; HUMAN; HUMAN TISSUE; HYPERLACTATEMIA; HYPERREFLEXIA; INTELLECTUAL IMPAIRMENT; MALE; METABOLIC ACIDOSIS; MITOCHONDRIAL RESPIRATION; MUSCLE CELL; MUSCLE HYPOTONIA; MUSCLE TISSUE; MUSCLE TONE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SOUTHERN BLOTTING; ANALOGS AND DERIVATIVES; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMPLICATION; INFANT; INTELLECTUAL DISABILITY; MITOCHONDRIAL DISEASES; PSYCHOLOGY;

CARNITINE; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FEMALE; FOLIC ACID; HUMANS; HYPERLACTATEMIA; INFANT; INTELLECTUAL DISABILITY; MALE; MITOCHONDRIAL DISEASES; UBIQUINONE; VITAMINS;

EID: 84939524738     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16023870     Document Type: Article

References (46)

1. Jansen, D.E.; Krol, B.; Groothoff, J.W.; Post, D. People with intellectual disability and their health problems: A review of comparative studies. J. Intellect. Disabil. Res. 2004, 48, 93–102.
2. Haas, R.H.; Parikh, S.; Falk, M.J.; Saneto, R.P.; Wolf, N.I.; Darin, N.; Cohen, B.H. Mitochondrial disease: A practical approach for primary care physicians. Pediatrics 2007, 120, 1326–1333.
3. Sherr, E.H.; Shevell, M.I. Global developmental delay and mental retardation/intellectual disability. In Pediatric Neurology: Principles and Practice, 5th ed.; Swaiman, K.F., Ashwal, S., Ferriero, D.M., Schor, N.F., Eds.; Elsevier Saunders: Philadelphia, PA, USA, 2012; pp. 554–574.
4. American Association of Intellectual and Developmental Disabilities (AAIDD). Definition of Intellectual Disability. Available online: http://aaidd.org/intellectual-disability/definition (accessed on 11 July 2013).
5. Luckasson, R.; Reeve, A. Naming, defining, and classifying mental retardation. Ment. Retard. 2001, 39, 47–52.
6. Oeseburg, B.; Jansen, D.E.; Groothoff, J.W.; Dijkstra, G.J.; Reijneveld, S.A. Emotional and behavioural problems in adolescents with intellectual disability with and without chronic diseases. J. Intellect. Disabil. Res. 2010, 54, 81–89.
7. Van Karnebeek, C.D.; Stockler, S. Treatable inborn errors of metabolism causing intellectual disability: A systematic literature review. Mol. Genet. Metab. 2012, 105, 368–381.
8. Bokhoven, H. Genetic and epigenetic networks in intellectual disabilities. Annu. Rev. Genet. 2011, 45, 81–104.
9. Sherr, E.H.; Michelson, D.J.; Shevell, M.I.; Moeschler, J.B.; Gropman, A.L.; Ashwal, S. Neurodevelopmental disorders and genetic testing: Current approaches and future advances. Ann. Neurol. 2013, 74, 164–170.
10. Baker, K.; Raymond, F.L.; Bass, N. Genetic investigation for adults with intellectual disability: Opportunities and challenges. Curr. Opin. Neurol. 2012, 25, 150–158.
11. Chinnery, P.F. Mitochondrial disorders overview. In GeneReviews®; Pagon, R.A., Adam, M.P., Ardinger, H.H., Bird, T.D., Dolan, C.R., Fong, C.T., Smith, R.J.H., Stephens, K., Eds.; University of Washington: Seattle, WA, USA, 1993–2014.
12. Friedman, S.D.; Shaw, D.W.; Ishak, G.; Gropman, A.L.; Saneto, R.P. The use of neuroimaging in the diagnosis of mitochondrial disease. Dev. Disabil. Res. Rev. 2010, 16, 129–135.
13. Bernier, F.P.; Boneh, A.; Dennett, X.; Chow, C.W.; Cleary, M.A.; Thorburn, D.R. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002, 59, 1406–1411.
14. Wolf, N.I.; Smeitink, J.A. Mitochondrial disorders: A proposal for consensus diagnostic criteria in infants and children. Neurology 2002, 59, 1402–1405.
15. Thorburn, D.R.; Sugiana, C.; Salemi R.; Kirby, D.M.; Worgan, L.; Ohtake, A.; Ryan, M.T. Biochemical and molecular diagnosis of mitochondrial respiratory chain disorders. Biochim. Biophys. Acta 2004, 1659, 121–128.
16. Verity, C.M.; Winstone, A.M.; Stellitano, L.; Krishnakumar, D.; Will, R.; McFarland, R. The clinical presentation of mitochondrial diseases in children with progressive intellectual and neurological deterioration: A national, prospective, population-based study. Dev. Med. Child Neurol. 2010, 52, 434–440.
17. McFarland, R.; Taylor, R.W.; Turnbull, D.M. A neurological perspective on mitochondrial disease. Lancet Neurol. 2010, 9, 829–840.
18. Nissenkorn, A.; Zeharia, A.; Lev, D.; Watemberg, N.; Fattal-Valevski, A.; Barash, V.; Gutman, A.; Harel, S.; Lerman-Sagie, T. Neurologic presentations of mitochondrial disorders. J. Child Neurol. 2000, 15, 44–48.
19. American Psychiatric Association. Intellectual disability. In Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American Psychiatric Publication: Arlington, VA, USA, 2013; p. 33.
20. Di Mauro, S.; Schon, E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 2003, 348, 2656–2668.
21. Weissman, J.R.; Kelley, R.I.; Bauman, M.L.; Cohen, B.H.; Murray, K.F.; Mitchell, R.L.; Kern, R.L.; Natowicz, M.R. Mitochondrial disease in autism spectrum disorder patients: A cohort analysis. PLoS One 2008, 3, e3815.
22. Zeviani, M.; Carelli, V. Mitochondrial disorders. Curr. Opin. Neurol. 2007, 20, 564–571.
23. Shevell, M. Global developmental delay and mental retardation or intellectual disability: Conceptualization, evaluation, and etiology. Pediatr. Clin. N. Am. 2008, 55, 1071–1084.
24. Valanne, L.; Ketonen, L.; Majander, A.; Suomalainen, A.; Pihko, H. Neuroradiologic findings in children with mitochondrial disorders. Am. J. Neuroradiol. 1998, 19, 369–377.
25. Barragan-Campos, H.M.; Valee, J.N.; Lo, D.; Barrera-Ramírez, C.F.; Argote-Greene, M.; Sánchez-Guerrero, J.; Estañol, B.; Guillevin, R.; Chiras, J. Brain magnetic resonance imaging findings in patients with mitochondrial cytopathies. Arch. Neurol. 2005, 62, 737–742.
26. Gropman, A.L. Neuroimaging in mitochondrial disorders. Neurotherapeutics 2013, 10, 273–285.
27. Saneto, R.P.; Friedman, S.D.; Shaw, D.W. Neuroimaging of mitochondrial disease. Mitochondrion 2008, 8, 396–413.
28. Watemberg, N.; Silver, S.; Harel, S.; Lerman-Sagie, T. Significance of microcephaly among children with developmental disabilities. J. Child Neurol. 2002, 17, 117–122.
29. Bindoff, L.A.; Engelsen, B.A. Mitochondrial diseases and epilepsy. Epilepsia 2012, 53, 92–97.
30. Koenig, M.K. Presentation and diagnosis of mitochondrial disorders in children. Pediatr. Neurol. 2008, 38, 305–313.
31. Anitha, A.; Nakamura, K.; Thanseem, I.; Matsuzaki, H.; Miyachi, T.; Tsujii, M.; Iwata, Y.; Suzuki, K.; Sugiyama, T.; Mori, N. Down-regulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol. 2013, 23, 294–302.
32. Rossignol, D.A.; Frye, R.E. Mitochondrial dysfunction in autism spectrum disorders: A systematic review and meta-analysis. Mol. Psychiatry 2011, 17, 290–314.
33. Nissenkorn, A.; Zeharia, A.; Lev, D.; Fatal-Valevskic, A.; Barashd, V.; Gutmand, A.; Harelc, S.; Lerman-Sagiea, T. Multiple presentation of mitochondrial disorders. Arch. Dis. Child. 1999, 81, 209–214.
34. Pfeffer, G.; Majamaa, K.; Turnbull, D.M.; Thorburn, D.; Chinnery, P.F. Treatment for mitochondrial disorders. Cochrane Database Syst. Rev. 2012, 4, CD004426.
35. Di Mauro, S.; Mancuso, M. Mitochondrial diseases: Therapeutic approaches. Biosci. Rep. 2007, 27, 125–137.
36. Chinnery, P.F.; Turnbull, D.M. Epidemiology and treatment of mitochondrial disorders. Am. J. Med. Genet. 2001, 106, 94–101.
37. Avula, S.; Parikh, S.; Demarest, S.; Kurz, J.; Gropman, A. Treatment of mitochondrial disorders. Curr. Treat. Options Neurol. 2014, 16, 292.
38. Frye, R.E.; Rossignol, D.A. Treatments for biomedical abnormalities associated with autism spectrum disorder. Front. Pediatr. 2014, 2, 66.
39. Connolly, B.H.; McClune, N.O.; Gatlin, R. Concurrent validity of the Bayley-III and the peabody developmental motor scale-2. Pediatr. Phys. Ther. 2012, 24, 345–352.
40. Goldin, R.L.; Matson, J.L.; Beighley, J.S.; Jang, J. Autism spectrum disorder severityas a predictor of Battelle Developmental Inventory—Second edition (BDI-2) scores in toddlers. Dev. Neurorehabil. 2014, 17, 39–43.
41. Raven, J.; Raven, J.C.; Court, J. Raven Manual: Standard Colored Progressive Matrices; Oxford Psychologists Press: London, UK, 1998.
42. Herrero-Martín, M.D.; Pineda, M.; Briones, P.; López-Gallardo, E.; Carreras, M.; Benac, M.; Angel Idoate, M.; Vilaseca, M.A.; Artuch, R.; López-Pérez, M.J., et al. A new pathologic mitochondrial DNA mutation in the cytochrome oxidase subunit I (MT-CO1). Hum. Mutat. 2008, 29, E112–E122.
43. Marcuello, A.; González-Alonso, J.; Calbet, J.A.; Damsgaard, R.; López-Pérez, M.J.; Díez-Sánchez, C. Skeletal muscle mitochondrial DNA content in exercising humans. J. Appl. Physiol. 1985, 99, 1372–1377.
44. Genova, M.L.; Castelluccio, C.; Fato, R. Major changes in complex I activity in mitochondria from aged rats may not be detected by direct assay of NADH:coenzyme Q reductase. Biochem. J. 1995, 311, 105–109.
45. Trumbeckaite, S.; Opalka, J.R.; Neuhof, C.; Zierz, S.; Gellerich, F.N. Different sensitivity of rabbit heart and skeletal muscle to endotoxin-induced impairment of mitochondrial function. Eur. J. Biochem. 2001, 268, 1422–1429.
46. Montero, R.; Artuch, R.; Briones, P.; Nascimento, A.; García-Cazorla, A.; Vilaseca, M.A.; Śnchez-Alćzar, J.A.; Navas, P.; Montoya, J.; Pineda, M. Muscle coenzyme Q10 concentrations in patients with probable and definite diagnosis of respiratory chain disorders. Biofactors. 2005, 25, 109–115.